Pharmarise Holdings Corp. | Balance Sheet
Fiscal year is June-May. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,643
3,884
3,344
3,745
3,653
Total Accounts Receivable
3,612
2,794
3,309
1,878
2,864
Inventories
978
1,133
1,952
2,236
2,106
Other Current Assets
324
448
467
500
496
Total Current Assets
8,558
8,258
9,072
8,361
9,122
Net Property, Plant & Equipment
6,506
6,646
6,916
7,011
6,503
Total Investments and Advances
1,598
1,573
2,386
2,042
448
Long-Term Note Receivable
220
233
173
122
31
Intangible Assets
7,210
6,795
6,420
6,170
5,642
Other Assets
418
434
517
536
2,136
Total Assets
24,879
24,226
25,667
24,540
24,265
ST Debt & Current Portion LT Debt
3,591
3,009
3,501
3,045
3,619
Accounts Payable
4,961
6,257
5,856
5,402
5,456
Income Tax Payable
435
272
202
226
410
Other Current Liabilities
1,126
1,087
1,177
1,128
1,284
Total Current Liabilities
10,112
10,625
10,736
9,801
10,769
Long-Term Debt
8,455
7,162
7,836
7,993
6,993
Provision for Risks & Charges
406
391
521
553
604
Deferred Taxes
335
286
164
297
379
Other Liabilities
242
237
318
288
268
Total Liabilities
19,251
18,415
19,430
18,635
18,636
Common Equity (Total)
5,460
5,642
5,522
5,442
5,437
Total Shareholders' Equity
5,460
5,642
5,522
5,442
5,437
Total Equity
5,629
5,811
6,237
5,900
5,624
Liabilities & Shareholders' Equity
24,879
24,226
25,667
24,535
24,260
Accumulated Minority Interest
169
169
715
458
187
About Pharmarise Holdings
View Profile
